Hematology TimesTeam creates guidelines on CAR T-cell-related toxicitySeptember 20, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCHMP recommends approval of generic imatinibSeptember 18, 2017CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
Hematology NewsHow would you treat ... recurrent pre-B ALL in a 24-year-old woman?September 16, 2017ALL
Hematology TimesImmune status linked to outcomes of CAR T-cell therapySeptember 15, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesReport details progress, obstacles in cancer research and careSeptember 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated IssuesAMLALL
Hematology NewsCB-5083 showed significant activity against B-ALLSeptember 9, 2017ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesCCSs have higher burden of chronic conditionsSeptember 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFDA approves first CAR T-cell therapy to treat ALLAugust 31, 2017Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesFDA approves drug to treat CRS induced by CAR T-cell therapyAugust 31, 2017Leukemia, Myelodysplasia, TransplantationALL
Hematology NewsFDA approves first gene therapy – tisagenlecleucel for ALLAugust 30, 2017ALLLeukemia, Myelodysplasia, TransplantationPediatricsImmuno-oncology
Hematology News‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in costAugust 23, 2017ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesTriplet eradicates B-ALL, prolongs survival in miceAugust 23, 2017Leukemia, Myelodysplasia, TransplantationALL
Hematology NewsInotuzumab ozogamicin tied to sinusoidal obstruction syndrome in ALLAugust 21, 2017ThrombosisALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesFDA approves inotuzumab ozogamicin for rel/ref ALLAugust 18, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology NewsInotuzumab ozogamicin approved for relapsed/refractory ALLAugust 17, 2017ALLLeukemia, Myelodysplasia, Transplantation
